Exane Derivatives Edwards Lifesciences Corp Transaction History

Exane Derivatives

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$86.5 - $128.27 $15,829 - $23,473	-183 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$101.96 - $128.34 $37,725 - $47,485	-370 Reduced 66.91%	183 $21,000
Q4 2021 Jan 28, 2022	SELL	$106.37 - $130.68 $72,969 - $89,646	-686 Reduced 55.37%	553 $71,000
Q3 2021 Oct 26, 2021	SELL	$102.91 - $122.75 $6,689 - $7,978	-65 Reduced 4.98%	1,239 $140,000
Q2 2021 Jul 28, 2021	SELL	$83.84 - $104.76 $41,500 - $51,856	-495 Reduced 27.52%	1,304 $135,000
Q1 2021 Apr 30, 2021	SELL	$78.68 - $90.67 $69,474 - $80,061	-883 Reduced 32.92%	1,799 $150,000
Q4 2020 Jan 27, 2021	SELL	$71.69 - $91.23 $178,938 - $227,710	-2,496 Reduced 48.2%	2,682 $244,000
Q3 2020 Oct 06, 2020	SELL	$67.19 - $87.44 $14,109 - $18,362	-210 Reduced 3.9%	5,178 $413,000
Q2 2020 Jul 10, 2020	BUY	$57.54 - $76.95 $309,910 - $414,452	5,386 Added 269300.0%	5,388 $372,000
Q2 2019 Jul 12, 2019	SELL	$55.74 - $64.41 $1,560 - $1,803	-28 Reduced 93.33%	2 $0
Q3 2018 Oct 24, 2018	BUY	$45.7 - $58.03 $137 - $174	3 Added 11.11%	30 $0
Q2 2018 Jul 19, 2018	BUY	$42.45 - $51.3 $212 - $256	5 Added 22.73%	27 $0
Q1 2018 Apr 30, 2018	SELL	$37.19 - $47.45 $44,293 - $56,512	-1,191 Reduced 98.19%	22 $0
Q4 2017 Jan 29, 2018	BUY	$33.79 - $39.39 $32,472 - $37,853	961 Added 381.35%	1,213 $0
Q3 2017 Oct 18, 2017	BUY	$36.29 - $38.83 $9,145 - $9,785	252	252 $0

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.